BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30952644)

  • 21. Hearing loss in a pediatric patient following cisplatin chemotherapy and subsequent exposure to excessive noise.
    Peleva E; Aloy E; Carret AS; Daniel SJ
    Int J Pediatr Otorhinolaryngol; 2014 Dec; 78(12):2301-4. PubMed ID: 25439704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cisplatin ototoxicity: series of cases].
    Mota LA; Melo MS; Santos MH; de Albuquerque KM; Tavares Cde L
    Rev Assoc Med Bras (1992); 2007; 53(4):370-3. PubMed ID: 17823744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy.
    Sanchez VA; Shuey MM; Dinh PC; Monahan PO; Fosså SD; Sesso HD; Dolan ME; Einhorn LH; Vaughn DJ; Martin NE; Feldman DR; Kroenke K; Fung C; Frisina RD; Travis LB
    J Clin Oncol; 2023 Apr; 41(12):2211-2226. PubMed ID: 36626694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
    Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
    Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further Investigation of the Role of
    Drögemöller BI; Brooks B; Critchley C; Monzon JG; Wright GEB; Liu G; Renouf DJ; Kollmannsberger CK; Bedard PL; Hayden MR; Gelmon KA; Carleton BC; Ross CJD
    Clin Cancer Res; 2018 Apr; 24(8):1866-1871. PubMed ID: 29358504
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurochemistry of the peripheral and central auditory system after ototoxic drug exposure: implications for tinnitus.
    Rybak LP
    Int Tinnitus J; 2005; 11(1):23-30. PubMed ID: 16419684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.
    Drögemöller BI; Monzon JG; Bhavsar AP; Borrie AE; Brooks B; Wright GEB; Liu G; Renouf DJ; Kollmannsberger CK; Bedard PL; Aminkeng F; Amstutz U; Hildebrand CA; Gunaretnam EP; Critchley C; Chen Z; Brunham LR; Hayden MR; Ross CJD; Gelmon KA; Carleton BC
    JAMA Oncol; 2017 Nov; 3(11):1558-1562. PubMed ID: 28448657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy.
    Niemensivu R; Saarilahti K; Ylikoski J; Aarnisalo A; Mäkitie AA
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2509-14. PubMed ID: 26685859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lifetime noise exposure on the middle-age human auditory brainstem response, tinnitus and speech-in-noise intelligibility.
    Valderrama JT; Beach EF; Yeend I; Sharma M; Van Dun B; Dillon H
    Hear Res; 2018 Aug; 365():36-48. PubMed ID: 29913342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.
    Shin YS; Song SJ; Kang S; Hwang HS; Jung YS; Kim CH
    J Appl Toxicol; 2014 Feb; 34(2):191-204. PubMed ID: 23297007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.
    Dolan ME; El Charif O; Wheeler HE; Gamazon ER; Ardeshir-Rouhani-Fard S; Monahan P; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Fung C; Kim J; Fossa SD; Hertz DL; Mushiroda T; Kubo M; Einhorn LH; Cox NJ; Travis LB;
    Clin Cancer Res; 2017 Oct; 23(19):5757-5768. PubMed ID: 28611204
    [No Abstract]   [Full Text] [Related]  

  • 33. Recovery from cisplatin-induced ototoxicity: a case report and review.
    Truong MT; Winzelberg J; Chang KW
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1631-8. PubMed ID: 17706797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.
    Brown AL; Lupo PJ; Okcu MF; Lau CC; Rednam S; Scheurer ME
    Cancer Med; 2015 Nov; 4(11):1679-86. PubMed ID: 26400460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of resveratrol against cisplatin-induced ototoxicity in HEI-OC1 auditory cells.
    Lee SH; Kim HS; An YS; Chang J; Choi J; Im GJ
    Int J Pediatr Otorhinolaryngol; 2015 Jan; 79(1):58-62. PubMed ID: 25434479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
    Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
    Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S; Del Valle Á; Chuang A; Becker A
    Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
    Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
    Xu H; Robinson GW; Huang J; Lim JY; Zhang H; Bass JK; Broniscer A; Chintagumpala M; Bartels U; Gururangan S; Hassall T; Fisher M; Cohn R; Yamashita T; Teitz T; Zuo J; Onar-Thomas A; Gajjar A; Stewart CF; Yang JJ
    Nat Genet; 2015 Mar; 47(3):263-6. PubMed ID: 25665007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
    Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.